Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,628 | -6,722 | 7,709 | -8,693 | -59,383 |
| Depreciation Amortization | 660 | 502 | 476 | 164 | 988 |
| Accounts receivable | -789 | -5,021 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,867 | -1,826 | -1,959 | -1,840 | N/A |
| Other Working Capital | -15,490 | -20,308 | -17,891 | 6,711 | 9,485 |
| Other Operating Activity | 9,502 | 12,082 | 3,691 | 3,067 | 980 |
| Operating Cash Flow | $-23,612 | $-21,293 | $-7,974 | $-591 | $-47,930 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,701 | 12,750 | N/A | 9,250 | N/A |
| PPE Investments | -750 | -437 | -436 | N/A | -294 |
| Sale Of Investment | N/A | N/A | 12,757 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -44 | 0 | 75,449 |
| Investing Cash Flow | $-3,451 | $12,313 | $12,277 | $9,250 | $75,155 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 227 | 121 | 102 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -148 | 0 | -246 |
| Financing Cash Flow | $227 | $121 | $-46 | $N/A | $-246 |
| Exchange Rate Effect | -595 | 388 | -90 | -221 | 18 |
| Beginning Cash Position | 105,663 | 105,663 | 106,007 | 105,663 | 79,010 |
| End Cash Position | 78,232 | 97,192 | 110,174 | 114,101 | 106,007 |
| Net Cash Flow | $-27,431 | $-8,471 | $4,167 | $8,438 | $26,997 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,612 | -21,293 | -7,974 | -591 | -47,930 |
| Capital Expenditure | -750 | -437 | -436 | N/A | N/A |
| Free Cash Flow | -24,362 | -21,730 | -8,410 | -591 | -47,930 |